Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06854575 · ClinicalTrials.gov registry record · NA
A Safety and Efficacy Study of a Nutraceutical in Aging Males With Thinning Hair
A NA study, sponsored by Nutraceutical Wellness.
- Terminated
- Registry status
- NA
- Development phase
- 155
- Enrollment target
NCT06854575: Clinical Trial NA study, sponsored by Nutraceutical Wellness.
NCT06854575 is a NA study that was terminated before completion, run by Nutraceutical Wellness. The registered enrollment target is 155 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06854575, a NA study, was terminated before completion, sponsored by Nutraceutical Wellness.
- TERMINATED
- Registry status
- NA
- Development phase
- 155 participants
- Enrollment target
Study Summary
A study to assess the safety and efficacy of a dietary supplement when used over the course of 9 months by men with self-perceived hair thinning.
Primary Outcome
Blinded Investigator mean Hair Growth Global Improvement Scale rating at 6 months for treatment group as compared to placebo
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Dietary Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2025-03-10 |
| Est. Completion | 2025-09-15 |
| Phase | NA |
Why NCT06854575 stopped before completion
NCT06854575 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06854575 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06854575 about?
NCT06854575 is a clinical study titled "A Safety and Efficacy Study of a Nutraceutical in Aging Males With Thinning Hair". A study to assess the safety and efficacy of a dietary supplement when used over the course of 9 months by men with self-perceived hair thinning.
What is the current status of trial NCT06854575?
This trial is currently terminated. It is a NA study. The enrollment target is 155 participants. The study started on 2025-03-10. Estimated completion is 2025-09-15.
What interventions are being tested in trial NCT06854575?
The interventions under investigation include: Placebo (OTHER), Dietary Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06854575?
This trial is sponsored by Nutraceutical Wellness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06854575's enrollment target sits among peer trials
155 656th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI